HIF1A and neoplasm: Available data show that HIF-1α activation may also inhibit the effects of toxic reactive oxygen species (ROS) on tumor cells and may modulate glycolysis and pyruvate metabolism, as well as cancer cell metastatic potential and resistance to oncotherapy [84].